pentadecapeptide vs bpc 157 (capitals) prevented muscle atrophy and BPC-157 - Xeno Peptides
Description
10.1093/annonc/mdx096 113
doi:10.2337/dc12-2625 2
BPC-157 is a research peptide not approved by Health Canada for human therapeutic use
Weekly dose range: 2502400 mcg (0.252.4 mg) once weekly (gradual escalation protocol)
Schedule Your Appointment Today!
Therefore the trials will not happen, and BPC-157 will sit in regulatory limbo while clinics sell it under the "research use only" loophole
